INS and type 1 diabetes mellitus: Importantly, retention of even small amounts of C-peptide has been demonstrated to reduce the risk of hypoglycemic events, the most significant cause of mortality with insulin therapy, as well as reducing the incidence of complications of T1D [54,55].